229 related articles for article (PubMed ID: 32108932)
1. Medical Treatment of Gastrointestinal Neuroendocrine Neoplasms.
Tsoli M; Alexandraki K; Xanthopoulos C; Kassi E; Kaltsas G
Horm Metab Res; 2020 Aug; 52(8):614-620. PubMed ID: 32108932
[TBL] [Abstract][Full Text] [Related]
2. Treatment Strategies for Metastatic Neuroendocrine Tumors of the Gastrointestinal Tract.
Cives M; Strosberg J
Curr Treat Options Oncol; 2017 Mar; 18(3):14. PubMed ID: 28286921
[TBL] [Abstract][Full Text] [Related]
3. Clinical Syndromes Related to Gastrointestinal Neuroendocrine Neoplasms.
Boutzios G; Kaltsas G
Front Horm Res; 2015; 44():40-57. PubMed ID: 26303703
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the Role of Theranostics in Grade 3 Neuroendocrine Neoplasms.
Waseem N; Aparici CM; Kunz PL
J Nucl Med; 2019 Jul; 60(7):882-891. PubMed ID: 30850504
[TBL] [Abstract][Full Text] [Related]
5. The archaic distinction between functioning and nonfunctioning neuroendocrine neoplasms is no longer clinically relevant.
Modlin IM; Moss SF; Gustafsson BI; Lawrence B; Schimmack S; Kidd M
Langenbecks Arch Surg; 2011 Dec; 396(8):1145-56. PubMed ID: 21523447
[TBL] [Abstract][Full Text] [Related]
6. Peptide Receptor Radionuclide Therapy for Advanced Gastroenteropancreatic Neuroendocrine Tumors - from oncology perspective.
Kolasińska-Ćwikła A; Łowczak A; Maciejkiewicz KM; Ćwikła JB
Nucl Med Rev Cent East Eur; 2018; 21(2):. PubMed ID: 29741203
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal endocrine tumours: medical management.
Arnold R; Frank M
Baillieres Clin Gastroenterol; 1996 Dec; 10(4):737-59. PubMed ID: 9113320
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin and dopamine receptor expression in neuroendocrine neoplasms: correlation of immunohistochemical findings with somatostatin receptor scintigraphy visual scores.
Diakatou E; Alexandraki KI; Tsolakis AV; Kontogeorgos G; Chatzellis E; Leonti A; Kaltsas GA
Clin Endocrinol (Oxf); 2015 Sep; 83(3):420-8. PubMed ID: 25808161
[TBL] [Abstract][Full Text] [Related]
9. SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2018).
González-Flores E; Serrano R; Sevilla I; Viúdez A; Barriuso J; Benavent M; Capdevila J; Jimenez-Fonseca P; López C; Garcia-Carbonero R
Clin Transl Oncol; 2019 Jan; 21(1):55-63. PubMed ID: 30535553
[TBL] [Abstract][Full Text] [Related]
10. Genomic Profiles and Current Therapeutic Agents in Neuroendocrine Neoplasms.
Ohmoto A; Morizane C
Curr Drug Targets; 2020; 21(4):389-405. PubMed ID: 31633473
[TBL] [Abstract][Full Text] [Related]
11. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy.
Oberg KE; Reubi JC; Kwekkeboom DJ; Krenning EP
Gastroenterology; 2010 Sep; 139(3):742-53, 753.e1. PubMed ID: 20637207
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal neuroendocrine neoplasms (GI-NENs): hot topics in morphological, functional, and prognostic imaging.
Danti G; Flammia F; Matteuzzi B; Cozzi D; Berti V; Grazzini G; Pradella S; Recchia L; Brunese L; Miele V
Radiol Med; 2021 Dec; 126(12):1497-1507. PubMed ID: 34427861
[TBL] [Abstract][Full Text] [Related]
13. Systemic treatment of neuroendocrine tumors with hepatic metastases.
Demirkan BH; Eriksson B
Turk J Gastroenterol; 2012; 23(5):427-37. PubMed ID: 23161287
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine tumor disease: an evolving landscape.
Frilling A; Akerström G; Falconi M; Pavel M; Ramos J; Kidd M; Modlin IM
Endocr Relat Cancer; 2012 Oct; 19(5):R163-85. PubMed ID: 22645227
[TBL] [Abstract][Full Text] [Related]
15. [Neuroendocrine tumours of the gastrointestinal tract].
Plöckinger U; Wiedenmann B
Z Gastroenterol; 2004 Jun; 42(6):517-27. PubMed ID: 15190448
[TBL] [Abstract][Full Text] [Related]
16. Hepatic surgery for metastases from neuroendocrine tumors.
Sarmiento JM; Que FG
Surg Oncol Clin N Am; 2003 Jan; 12(1):231-42. PubMed ID: 12735141
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of tumour burden in stage IV neuroendocrine neoplasia: A comparison between pancreatic and gastrointestinal localizations.
Panzuto F; Pusceddu S; Faggiano A; Rinzivillo M; Brighi N; Prinzi N; Riccardi F; Iannicelli E; Maggio I; Femia D; Tafuto S; Manuzzi L; Di Sarno A; Annibale B; de Braud F; Campana D;
Pancreatology; 2019 Dec; 19(8):1067-1073. PubMed ID: 31587962
[TBL] [Abstract][Full Text] [Related]
18. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms.
Klöppel G
Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S1-16. PubMed ID: 22005112
[TBL] [Abstract][Full Text] [Related]
19. Evolution in the treatment of gastroenteropancreatic-neuroendocrine neoplasms, focus on systemic therapeutic options: a systematic review.
Pusceddu S; De Braud F; Festinese F; Bregant C; Lorenzoni A; Maccauro M; Milione M; Concas L; Formisano B; Leuzzi L; Mazzaferro V; Buzzoni R
Future Oncol; 2015; 11(13):1947-59. PubMed ID: 26161929
[TBL] [Abstract][Full Text] [Related]
20. [Digestive neuroendocrine tumors].
de Mestier L; Deguelte-Lardière S; Brixi H; Kianmanesh R; Cadiot G
Rev Med Interne; 2016 Aug; 37(8):551-60. PubMed ID: 26897113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]